ArticleChemMedChem2023

Hybrid Androgen Receptor Inhibitors Outperform Enzalutamide and EPI-001 in in vitro Models of Prostate Cancer Drug Resistance.

Radu Costin Bizga Nicolescu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.